Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-25-105183
Filing Date
2025-11-03
Accepted
2025-11-03 16:02:02
Documents
27
Period of Report
2025-12-15

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0261240-03.htm   iXBRL DEF 14A 1108457
6 GRAPHIC tbarchart_001.jpg GRAPHIC 583510
7 GRAPHIC tbarchart_002.jpg GRAPHIC 542985
8 GRAPHIC timage_001.jpg GRAPHIC 21254
9 GRAPHIC timage_002.jpg GRAPHIC 12342
10 GRAPHIC timage_003.jpg GRAPHIC 21198
11 GRAPHIC timage_004.jpg GRAPHIC 1611929
12 GRAPHIC timage_005.jpg GRAPHIC 1491350
13 GRAPHIC tmarlan_sig.jpg GRAPHIC 14305
14 GRAPHIC tproxy_001.jpg GRAPHIC 1528384
15 GRAPHIC tproxy_002.jpg GRAPHIC 1042022
16 GRAPHIC ttherapeuticsmd_logo.jpg GRAPHIC 38886
  Complete submission text file 0001213900-25-105183.txt   18949554

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE txmd-20251103.xsd EX-101.SCH 14075
3 XBRL DEFINITION FILE txmd-20251103_def.xml EX-101.DEF 9603
4 XBRL LABEL FILE txmd-20251103_lab.xml EX-101.LAB 45182
5 XBRL PRESENTATION FILE txmd-20251103_pre.xml EX-101.PRE 14279
29 EXTRACTED XBRL INSTANCE DOCUMENT ea0261240-03_htm.xml XML 492539
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-00100 | Film No.: 251443958
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)